Genprex Inc (NASDAQ:GNPX) has a beta value of -0.46 and has seen 1.52 million shares traded in the recent trading session. The company, currently valued at $6.48M, closed the recent trade at $0.23 per share which meant it lost -$0.05 on the day or -17.31% during that session. The GNPX stock price is -1678.26% off its 52-week high price of $4.09 and 4.35% above the 52-week low of $0.22.

Genprex Inc (NASDAQ:GNPX) trade information

Sporting -17.31% in the red today, the stock has traded in the red over the last five days, with the highest price hit on recent trading when the GNPX stock price touched $0.23 or saw a rise of 22.03%. Year-to-date, Genprex Inc shares have moved -72.63%, while the 5-day performance has seen it change -16.75%. Over the past 30 days, the shares of Genprex Inc (NASDAQ:GNPX) have changed -11.87%.

Genprex Inc (GNPX) estimates and forecasts

The company’s shares have lost -84.96% over the past 6 months.

If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was 27.47% over the past 5 years.

GNPX Dividends

Genprex Inc is expected to release its next earnings report in June this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.

Also the top two Mutual Funds that are holding company’s shares are Fidelity Concord Street Trust-Fidelity Extended Market Index Fund and VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund . As of Mar 31, 2025 , the former fund manager holds about 0.23% shares in the company for having 54.8 shares of worth $12933.0 while later fund manager owns 14.97 shares of worth $3534.0 as of Dec 31, 2024 , which makes it owner of about 0.06% of company’s outstanding stock.